||This article may require cleanup to meet Wikipedia's quality standards. The specific problem is: contains lots of incorrect grammar. (February 2015)|
|This article needs additional citations for verification. (February 2015)|
Bioceramics and bioglasses are ceramic materials that are biocompatible. Bioceramics are an important subset of biomaterials. Bioceramics range in biocompatibility from the ceramic oxides, which are inert in the body, to the other extreme of resorbable materials, which are eventually replaced by the materials which they were used to repairing. Bioceramics are used in many types of medical procedures. A primary medical procedure where they are used is implants. This article is primarily concerned with rigid materials commonly used as surgical implants, though some bioceramics are flexible. The ceramic materials used are not the same as porcelain type ceramic materials. Rather, bioceramics are closely related to either the body's own materials, or are extremely durable metal oxides.
Prior to 1925 the materials used in implant surgery were primarily relatively pure metals. However, these are not considered to be ceramics and are therefore outside the scope of this article. The success of these materials was surprising considering the relatively primitive surgical techniques. The 1930s marked the beginning of the era of better surgical techniques and also the first use of alloys such as Vitallium.
In 1969 L. L. Hench and others discovered that various kinds of glasses and ceramics could bond to living bone Hench was inspired with the idea on his way to a conference on materials. He was seated next to a colonel who had just returned from the Vietnam War. The colonel shared that after an injury the bodies of soldiers would often reject the implant. Hench was intrigued and began to investigate materials that would be biocompatible. The final product was a new material which he called Bioglass. This work inspired a new field called bioceramics. With the discovery of bioglass interest in bioceramics grew rapidly.
On April 26, 1988, the first international symposium on bioceramics was held in Kyoto, Japan.
Ceramics are now commonly used in the medical fields as dental, and bone implants. Artificial teeth, and bones are relatively commonplace. Surgical cermets are used regularly. Joint replacements are commonly coated with bioceramic materials to reduce wear and inflammatory response. Other examples of medical uses for bioceramics are in pacemakers, kidney dialysis machines, and respirators. The global demand on medical ceramics and ceramic components was about US$9.8 billion in 2010. It is forecast to have an annual growth of 6–7% in the following years, and the world market value will increase to US$15.3 billion by 2015 and reach US$18.5 billion by 2018.
Mechanical Properties and Composition
Bioceramics are meant to be used in extracorporeal circulation systems (dialysis for example) or engineered bioreactors. But is mostly common as implants. The Ceramics show innumerous applications as biomaterials due to their physicochemical properties. It is also inert in the human body, the hardness and resistance to abrasion also makes them useful for bones and teeth replacement. Some ceramics also have excellent resistance to friction making them useful to replace malfunctioning joints. More properties such as appearance and electrical insulation are also a concern for specific biomedical applications.
Some bioceramics, such as Alumina (Al2O3) are used with high pure phase and the lifespan is longer that the patient’s. It can be also used as inner ear ossicles, ocular prostheses, electrical insulation for pacemakers, catheter orifices and in numerous prototypes of implantable systems (cardiac pumps for example). Alumino-silicates are commonly used in dental prostheses, pure or in ceramic-polymer composites. The ceramic-polymer composites are a potential way to filling of cavities replacing amalgams suspected to have toxic effects. The aluminosilicates also have a glassy structure. Contrary to artificial teeth in resin, the color of tooth ceramic remains stable Zirconia doped with yttrium oxide has been proposed as a substitute for alumina for osteoarticular prostheses. The main advantages are a greater failure strength, and a good resistance to fatigue. Vitreous carbon has interesting properties, is light, resistant to wear and compatible to the blood. It is mostly cardiac valves replacement. The diamond can be used for the same application, but in coating form.
Bioactive ceramics are used for orthopedic, maxillofacial and plastic surgeons. They are used in case a loss of bone substance happens. Biodegradable ceramics will be resorbed by the organism and replaced by reconstructed tissue, whereas non-biodegradable ceramics are intended for a permanent implantation. Calcium phosphate-based ceramics constitute, at present, the preferred bone substitute in orthopedic and maxillofacial surgery. They are very similar to the mineral phase of the bone, by their structure and/or their chemical composition.
Calcium phosphates usually found in ceramics are:
– hydroxyapatite (HAP): Ca10(PO4)6(OH)2;
– tricalcium phosphate β (β TCP): Ca3 (PO4)2;
– mixtures of HAP and β TCP.
This type of material have pores which provides a good bone-implant interface, due to the increasement of surface area that encourages cell colonization and the revascularization. Besides this excellent property, it has smaller mechanical strength compared to the bone, turning high porous implants very delicate. Besides, since the Young's modulus of ceramics is generally much higher than that of the bone tissue, the implant can cause mechanical stresses at the bone interface.
Table 1: Bioceramics Applications 
|Artificial total hip, knee, shoulder, elbow, wrist||Reconstruct arthritic or fractured joints||High-density alumina, metal bioglass coatings|
|Bone plates, screws, wires||Repair fractures||Bioglass-metal fiber composite, Polysulfone-carbon fiber composite|
|Intramedullary nails||Align fractures||Bioglass-metal fiber composite, Polysulfone-carbon fiber composite|
|Harrington rods||Correct chronic spinal curvature||Bioglass-metal fiber composite, Polysulfone-carbon fiber composite|
|Permanently implanted artificial limbs||Replace missing extremities||Bioglass-metal fiber composite, Polysulfone-carbon fiber composite|
|Vertebrae Spacers and extensors||Correct congenital deformity||Al2O3|
|Spinal fusion||Immobilize vertebrae to protect spinal cord||Bioglass|
|Alveolar bone replacements, mandibular reconstruction||Restore the alveolar ridge to improve denture fit||Polytetra fluro ethylene (PTFE) - carbon composite, Porous Al2O3, Bioglass, dense-apatite|
|End osseous tooth replacement implants||Replace diseased, damaged or loosened teeth||Al2O3, Bioglass, dense hydroxyapatite, vitreous carbon|
|Orthodontic anchors||Provide posts for stress application required to change deformities||Bioglass-coated Al2O3, Bioglass coated vitallium|
Table 2: Mechanical Properties of Ceramic Biomaterials 
|Material||Young’s Modulus (GPa)||CompressiveStrength (MPa)||Bond strength (GPa)||Hardness||Density (g/cm3)|
|AW Glass Ceramic||118||1080||215||680||2.8|
A number of implanted ceramics have not actually been designed for specific biomedical applications. And are used in different implantable systems because of their properties and their good biocompatibility. Alumina is one of the most widely used multipurpose ceramics. There is also Alumino-silicates, Alumino-silicate glasses, Zirconia, Vitreous carbon and diamond carbon.
A number of other ceramics have been subjected to biomedical tests for implantation, without currently being developed industrially. Among these ceramics, we can cite silicon carbide, titanium nitrides and carbides, and boron nitride. TiN has been suggested as the friction surface in hip prostheses. While cell culture tests show a good biocompatibility, the analysis of implants shows significant wear, related to a delaminating of the TiN layer. Silicon carbide is another modern day ceramic which seems to provide good biocompatibility and can be used as bone implant.
Ceramics for specific uses, in addition to their traditional properties, have biological activity. It is also referred as bioactive ceramics. Calcium phosphates, Oxides and hydroxides are an example. There is also natural materials generally from animal origin, bioglasses and composites, which are a combination of mineral-organic composite materials such as HAP, alumina or titanium dioxide with the biocompatible polymers (polymethylmethacrylate): PMMA, poly(L-lactic) acid: PLLA, poly(ethylene). Composites can be differentiated as bioresorbable or non-bioresorbable. The nonbioresorbable composites are the result of the combination of a non-bioresorbable calcium phosphate (HAP) with a non-bioresorbable polymer (PMMA, PE). These materials should grow in the future on account of the great many combination possibilities and their aptitude at combining a biological activity with mechanical properties similar to those of the bone.
Bioceramics are materials that are pretty used and are being well known all over the world, specifically in the biomedical area. It is explained by their properties like good anticorrosion, great biocompatibility and matching shade. It makes bioceramics a security and confidence material for medical usages. Zirconia ceramic revealed its bioinertness and noncytotoxicity. Carbon with similar mechanical properties of bone is an exciting candidate, for it elicits blood compatibility, no tissue reaction and nontoxicity to cells. None of the three-bioinert ceramics exhibited bonding with the bone. However, the bioactivity of the bioinert ceramics can be achieved by forming composites with bioactive ceramics. Bioglass and glass ceramics are nontoxic and chemically bond to bone. Glass ceramics elicit osteoinductive property. Calcium phosphate ceramics exhibit nontoxicity to tissues, bioresorption and osteoinductive property. The ceramic particulate reinforcement has led to the choice of more materials for implant applications that include ceramic/ceramic, ceramic/polymer, ceramic/metal composites. Among these choice of composites ceramic/polymer composites have found to release toxic elements into the surrounding tissues and possess the limitations of organization into definite shape. Metals face corrosion related problems and ceramic coatings on metallic implants degrade as the time progress during long time applications. Ceramic/ceramic composites enjoy superiority due to similarity with bone minerals, exhibiting biocompatibility and are able to be shaped into definite size. Hence, the biological activity of bioceramics has to be understood through various in vitro and in vivo studies and the knowledge on mechanical feature would join its hand to play a key role for the choice of the bioceramic in accord to the site of implantation and their broad implication as implants.
Technical ceramics are composed of raw materials generally as powder and of natural or synthetic chemical additives, favoring either compaction (hot, cold orisostatic), or setting (hydraulic or chemical) or accelerating sintering processes. According to the formulation of the bioceramic and the shaping process used, it can obtain ceramics, dense or with variable porosity, cements, ceramic depositions or ceramic composites. Another way of material processing is developing; it is based on the biomimetic processes aiming at imitating natural and biological processes and offers the possibility of making these bioceramics at ambient temperature than that of conventional or hydrothermal processes [GRO 96]. The prospect of using these very low forming temperatures opens up possibilities for mineral organic combinations with improved biological properties by the addition of proteins and biologically active molecules (growth factors, antibiotics, anti-tumor agents, etc.). However, these materials have poor mechanical properties which can be improved, partially, by combinations with bonding proteins.
The bioactive materials available commercially for clinical use are 45S5 bioactive glass, A/W bioactive glass ceramic, dense synthetic HA, or bioactive composites, such as a polyethylene–HA mixture. All the above bioactive materials form an interfacial bond with adjacent tissue.
High-purity alumina bioceramics are currently commercially available from various producers. Morgan Advanced Ceramics (MAC) (Worcestershire, UK) began manufacturing orthopaedic devices in 1985 and quickly became a recognized supplier of ceramic femoral heads for hip replacements. MAC Bioceramics has the longest clinical history for alumina ceramic materials, HIP Vitox® alumina since 1985. Some calcium-deficient phosphates with an apatite structure were thus commercialized as ‘tricalcium phosphate’ even though they did not exhibit the expected crystalline structure of tricalcium phosphate.
At the present time, numerous commercial products described as HA are available, in various physical forms (e.g. granules, specially designed blocks for specific applications) HA/polymer composite (HA/polyethyelene, HAPEXTM) is also commercially available as ear implants. HA is also now commonly used in abrasives and as a plasma-sprayed coating for orthopedic and dental implants.
One proposed use for bioceramics is the treatment of cancer. Two methods of treatment have been proposed; treatment through hyperthermia, and radiotherapy. Hyperthermia treatment involves implanting a bioceramic material that contains a ferrite or other magnetic material. The area is then exposed to alternating magnetic field, which causes the implant and surrounding area to heat up. Alternatively the bioceramic materials can be doped with β-emitting materials and implanted into the cancerous area.
Other trends include engineering the materials for specific tasks. Ongoing research involves the chemistry, composition, and micro and nanostructures of the materials to improve their biocompatibility.
- P. Ducheyne, G. W. Hastings (editors) (1984) CRC metal and ceramic biomaterials vol 1 ISBN 0-8493-6261-X
- J. F. Shackelford (editor)(1999) MSF bioceramics applications of ceramic and glass materials in medicine ISBN 0-87849-822-2
- H. Oonishi, H. Aoki, K. Sawai (editors) (1988) Bioceramics vol. 1 ISBN 0-912791-82-9
- Hench, Larry L. (1991). "Bioceramics: From Concept to Clinic" (PDF). Journal of the American Ceramic Society 74 (7): 1487. doi:10.1111/j.1151-2916.1991.tb07132.x.
- T. Yamamuro, L. L. Hench, J. Wilson (editors) (1990) CRC Handbook of bioactive ceramics vol II ISBN 0-8493-3242-7
- Kassinger, Ruth. Ceramics: From Magic Pots to Man-Made Bones. Brookfield, CT: Twenty-First Century Books, 2003, ISBN 978-0761325857
- D. Muster (editor) (1992) Biomaterials hard tissue repair and replacement ISBN 0-444-88350-9
- Kinnari, Teemu J.; Esteban, Jaime; Gomez-Barrena, Enrique; Zamora, Nieves; Fernandez-Roblas, Ricardo; Nieto, Alejandra; Doadrio, Juan C.; López-Noriega, Adolfo; Ruiz-Hernández, Eduardo; Arcos, Daniel; Vallet-Regí, María (2008). "Bacterial adherence to SiO2-based multifunctional bioceramics". Journal of Biomedical Materials Research Part A. doi:10.1002/jbm.a.31943.
- Market Report: World Medical Ceramics Market. Acmite Market Intelligence. 2011.
- Boch, Philippe, Niepce, Jean-Claude. (2010) Ceramic Materials: Processes, Properties and Applications. doi: 10.1002/9780470612415.ch12
- Hench LL. Bioceramics: From concept to clinic. J Amer CeramSoc 1991;74(7):1487–510.
- Thamaraiselvi, T. V., and S. Rajeswari. “Biological evaluation of bioceramic materials-a review.” Carbon 24.31 (2004): 172.
- . Kokubo. Bioceramics and Their Clinical Applications, Woodhead Publishing Limited, Cambridge, England, 2008 ISBN 978-1-84569-204-9
- Chai, Chou; Leong, Kam W (2007). "Biomaterials Approach to Expand and Direct Differentiation of Stem Cells". Molecular Therapy 15 (3): 467–80. doi:10.1038/sj.mt.6300084. PMC 2365728. PMID 17264853.
- Zhu, Xiaolong; Chen, Jun; Scheideler, Lutz; Altebaeumer, Thomas; Geis-Gerstorfer, Juergen; Kern, Dieter (2004). "Cellular Reactions of Osteoblasts to Micron- and Submicron-Scale Porous Structures of Titanium Surfaces". Cells Tissues Organs 178 (1): 13–22. doi:10.1159/000081089. PMID 15550756.
- Hao, L; Lawrence, J; Chian, KS (2005). "Osteoblast cell adhesion on a laser modified zirconia based bioceramic". Journal of Materials Science: Materials in Medicine 16 (8): 719–26. doi:10.1007/s10856-005-2608-3. PMID 15965741.